| --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | Disclaimers Cautionary Note Regarding Forward-Looking Statements Certain statements in this presentation may be considered "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or the Company's future finan ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to ______ Commission file number 001-39835 Benson Hill, Inc. (Exact name of registrant as specified in its charter) Delaware 85-337482 ...

INVESTOR DAY APRIL 5TH, 2022 Disclaimers Cautionary Note Regarding Forward-Looking Statements Certain statements in this presentation may be considered "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or the Company's future financial or operating performance and may be identified by words such as "may," "should," "expect," "intend," "will," "estima ...

Benson Hill, Inc. (NYSE:BHIL) Q4 2021 Earnings Conference Call March 28, 2022 8:30 AM ET Company Participants Ruben Mella - Senior Director, Investor Relations Matt Crisp - CEO Dean Freeman - CFO Conference Call Participants Kristen Owen - Oppenheimer Benjamin Theurer - Barclays Adam Samuelson - Goldman Sachs Brian Wright - ROTH Capital Partners Operator Good morning. Thank you for attending Benson Hill’s Full Year 2021 Earnings Call. My name is Emily and I will be your moderator. All lines will be muted du ...

BENSON ® HILL " FY 2021 Earnings March 28, 2022 Disclaimers Cautionary Note Regarding Forward-Looking Statements Certain statements in this presentation may be considered "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forwardlooking statements generally relate to future events or the Company's future financial or operating performance and may be identified by words such as "may," "should," "expect," "intend ...

Financial Position - As of December 31, 2021, the company had cash and cash equivalents of $182.7 million and an accumulated deficit of $280.6 million, with a net loss of $126.2 million for the year[92]. - The company had total current assets of $283,358,000 as of December 31, 2021, compared to $140,449,000 in 2020, representing a growth of about 102%[364]. - Cash and cash equivalents increased significantly to $78,963,000 in 2021 from $9,743,000 in 2020, showing a growth of approximately 711%[364]. - Total assets reached $534,897,000 in 2021, up from $231,785,000 in 2020, indicating an increase of about 131%[366]. - The accumulated deficit as of December 31, 2021, was $(280,569,000), compared to $(154,322,000) in 2020, reflecting a worsening of the deficit by approximately 82%[366]. - The company had cash and cash equivalents of $78,963 and marketable securities of $103,689 as of December 31, 2021, requiring additional financing prior to becoming profitable[383]. - The combined cash and marketable securities position was $182,652 as of December 31, 2021, sufficient to meet capital and liquidity requirements for at least the next 12 months[384]. Operating Performance - The company incurred negative cash flows from operating activities amounting to $117.8 million[92]. - Total revenues for 2021 were $147,212,000, an increase from $114,348,000 in 2020, representing a growth of approximately 29%[368]. - The company reported a gross loss of $945,000 in 2021, compared to a gross profit of $11,918,000 in 2020, indicating a significant decline in profitability[368]. - Total operating expenses rose to $122,130,000 in 2021, up from $71,735,000 in 2020, marking an increase of about 70%[368]. - The net loss for 2021 was $126,247,000, compared to a net loss of $67,159,000 in 2020, which is an increase in losses of approximately 88%[370]. - The company reported a net cash used in operating activities of $117,750,000 in 2021, compared to $52,678,000 in 2020[374]. Research and Development - Research and development expenses were $40.6 million for the year ended December 31, 2021, compared to $29.5 million in 2020 and $24.8 million in 2019[110]. - Research and development expenses increased to $40,578,000 in 2021 from $29,457,000 in 2020, reflecting a rise of approximately 38%[368]. Competition and Market Risks - The company expects to face significant competition in the plant-based products market, which may impact its ability to achieve market acceptance for its products[102]. - The successful commercialization of products may be challenged by public perceptions and regulatory environments regarding gene-edited products[122][124]. - The company is exposed to fluctuations in agricultural commodity prices, which could impact financial performance[140]. - The company may experience fluctuations in agricultural commodity prices, affecting its costs for purchasing soybeans for processing[350]. Legal and Regulatory Risks - The company is subject to numerous environmental, health, and safety laws, which could be costly and time-consuming to comply with, potentially impairing research and development efforts[180]. - The company faces regulatory challenges that could arise from the inadvertent sale of products in jurisdictions where they are not approved for distribution, leading to significant expenses and management attention[176]. - The company is subject to food safety regulations, and failure to comply could result in substantial fines and penalties, adversely affecting financial condition and operations[181]. - The regulatory environment for the company's products is uncertain and evolving, which could increase development time and costs[171]. Management and Personnel - The company relies on key management personnel, and losing them could adversely affect business operations and growth[142]. - Competition for skilled employees in research and development is intense, and failure to attract and retain such talent could hinder growth[144]. - The company may face challenges in attracting and retaining qualified personnel due to increased compliance costs and regulatory requirements[148]. Financing and Capital Structure - The company expects to need to raise additional funding to achieve strategic goals and execute its business plan[92]. - The company anticipates that it may seek additional funds through public or private equity or debt financings, which could result in dilution to stockholders[96]. - The company borrowed $80 million under a new debt facility to finance the purchase price of the Creston acquisition, with the potential to access an additional $20 million if certain milestones are achieved[158]. - The Avenue Capital Loan amounts to an aggregate of $80 million, with an additional $20 million contingent on achieving certain milestones[212]. - The Loan Agreement requires maintaining a "remaining months liquidity" of at least six months[215]. - The company may issue additional securities for investments or acquisitions, which could lead to dilution for existing stockholders[241]. Acquisitions and Growth - The company acquired a food-grade white flake and soy flour manufacturing operation in Creston, Iowa, in December 2021, and a soy crushing facility in Seymour, Indiana, in September 2021[154]. - The merger with Star Peak Corp II was completed on September 29, 2021, enhancing the company's capital structure[379]. - The company raised $285,378,000 from merger and PIPE financing, net of transaction costs[374]. Internal Controls and Compliance - A material weakness in internal control over financial reporting was identified, which could lead to misstatements in financial statements[132]. - The company is implementing a remediation plan for identified material weaknesses, including hiring additional accounting personnel[138]. Future Outlook - Future profitability is dependent on obtaining adequate financing, building customer relationships, and executing business strategies[386]. - The company may not be able to fund its longer-term capital and liquidity needs based solely on current cash balances and operating cash flow[95]. - Failure to generate sufficient revenues or achieve planned gross margins may require the company to modify or abandon planned expansions[387].

Benson Hill, Inc. (NYSE:BHIL) Q3 2021 Earnings Conference Call November 15, 2021 8:30 AM ET Corporate Participants Ruben Mella - Senior Director, Investor Relations Matt Crisp - Chief Executive Officer Deann Brunts - Chief Financial Officer Conference Call Participants Ben Theurer - Barclays Ruben Mella Good morning and welcome to Benson Hill's Third Quarter Earnings Call, our first as a publicly traded company. I am Ruben Mella's Senior Director of Investor Relations. We are excited to have the opportunity ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to ______ Commission file number 001-39835 Benson Hill, Inc. (Exact name of registrant as specified in its charter) Delaware 85-33 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to STAR PEAK CORP II (847) 905-4500 (Registrant's telephone number, including area code) Not Applicable (Former name or former address, if changed since last repo ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-fourth of one warrant STPC.U The New York Stock Exchange Shares of Class A common stock included as part of the units STPC The New York Stock Exchange Warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 STPC WS The New York Stock Exchange ...